Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 6, 2021

Primary Completion Date

December 12, 2023

Study Completion Date

March 8, 2024

Conditions

PolymyositisDermatomyositis

Interventions

DRUG

Umbilical Cord Lining Stem Cells

An IV infusion of ULSCs will be administered.

Trial Locations (1)

University of Florida, Gainesville

All Listed Sponsors

collaborator

Restem, LLC.

INDUSTRY

lead

University of Florida

OTHER

NCT04723303 - Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM) | Biotech Hunter | Biotech Hunter